Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years Read more
IDEAYA Biosciences Receives Fast Track Designation for Darovasertib Combination Therapy with Crizotinib for the Treatment of Metastatic Uveal Melanoma Read more
Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement Read more
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases Read more
European Medicines Agency accepts marketing authorisation application for momelotinib for the treatment of myelofibrosis Read more
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors Read more
Brazilian Regulatory Authority Grants Approval for Waylivra™ for Familial Partial Lipodystrophy Read more